KARE Biosciences

KARE BiosciencesKARE BiosciencesKARE Biosciences

KARE Biosciences

KARE BiosciencesKARE BiosciencesKARE Biosciences
  • Home
  • About Us
    • Pipeline
    • Our Publications
    • Our Patents
    • Our Team
    • Our Science
  • Science
    • COVID-19
    • Silicosis
    • Lupus Nephritis
    • Sickle Cell Disease
    • Neurological Disease
    • Cardiovascular Disease
  • News
    • Presentations
    • Our Blog
  • Contact
  • More
    • Home
    • About Us
      • Pipeline
      • Our Publications
      • Our Patents
      • Our Team
      • Our Science
    • Science
      • COVID-19
      • Silicosis
      • Lupus Nephritis
      • Sickle Cell Disease
      • Neurological Disease
      • Cardiovascular Disease
    • News
      • Presentations
      • Our Blog
    • Contact
  • Home
  • About Us
    • Pipeline
    • Our Publications
    • Our Patents
    • Our Team
    • Our Science
  • Science
    • COVID-19
    • Silicosis
    • Lupus Nephritis
    • Sickle Cell Disease
    • Neurological Disease
    • Cardiovascular Disease
  • News
    • Presentations
    • Our Blog
  • Contact

Our Publications

COVID-19

Treatment of COVID-19 pneumonia and acute respiratory distress with ramatroban

Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath

Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath

Martin L. Ogletree, Kate C. Chiang, Rashmi Kulshreshta, Aditya Agarwal, Ashutosh Agarwal, Ajay Gupta. Accepted for publication in Frontiers in Pharmacology. 2022.

Visit

Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath

Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath

Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath

Kate C. Chiang, John G. Rizk, Deanna J. Nelson, Lakshmanan Krishnamurti, Selvakumar Subbian, John D. Imig, Imran Khan, Srinivasa T. Reddy, Ajay Gupta. Expert Opin Ther Targets. 2022 Jan;26(1):13-28.

Visit

Kidney in the net of acute and long-haul coronavirus disease 2019

Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath

Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease

Kate C. Chiang, John D. Imig, Kamyar Kalantar-Zadeh, Ajay Gupta. Curr Opin Nephrol Hypertens. 2022 Jan 1;31(1):36-46.

Visit

Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease

Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease

Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease

Ajay Gupta, Kate C. Chiang. 2020. Medical Hypotheses,  143, art. no. 110122

Visit

Ramatroban as a Novel Immunotherapy for COVID-19

Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease

Ramatroban as a Novel Immunotherapy for COVID-19

Ajay Gupta, Kamyar Kalantar-Zadeh, Srinivasa T. Reddy. J Mol Genet Med. 2020; 14(3): 10.37421/jmgm.2020.14.457.

Visit

Add a footnote if this applies to your business

Copyright © 2024 KARE Biosciences - All Rights Reserved.


Powered by GoDaddy